| Catalog Number |
27113 |
| Medical Device Problem Code |
Human-Device Interface Problem (2949)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
08/21/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The protocol provided by bio-rad for testing the liquichek immunoassay premium control indicated the product contains human source materials and should be considered potentially infectious and handled with the same precautions used with patient specimens in accordance with good laboratory practice.Each human donor unit used to manufacture this product was tested as required by fda accepted methods.Tests results were non-reactive or negative for evidence of infection due to human immunodeficiency virus (hiv), hepatitis b virus (hbv) and hepatitis c virus (hcv).This product may also contain other human source materials for which there are no approved tests.In accordance with good laboratory practice, all human source material should be considered potentially infectious and handled with the same precautions used with patient specimens.
|
| |
|
Event or Problem Description
|
|
On 08/21/2019, a nurse from (b)(6) hospital called bio-rad qsd technical support to report a potential adverse event.The nurse stated that one employees got their right eye splashed with level 3 of liquichek immunoassay premium control, lot # 27373.The eye was rinsed off.The employee was not wearing protective eye wear.The employee has the vaccination for (b)(6).The nurse practitioner will do a baseline testing and make decision about starting the employee on prophylactic treatment.The nurse indicated having a copy of the sds and bio-rad provided a copy of the package insert.
|
| |
|
Search Alerts/Recalls
|